Group Compassionate Mind Training for Adults Experiencing the Menopause Transition

May 1, 2026 updated by: University College, London

The Feasibility and Effects of Group Compassionate Mind Training for Adults Experiencing the Menopause Transition: a Preliminary Investigation

Menopause transition occurs naturally for women aged 45-55. In addition to the hormone changes, there are often changes in other areas of life including low mood, anxiety, 'brain fog' and embarrassment. Some people may not be eligible for or want to receive hormone replacement therapy, therefore psychological treatments for menopause have been investigated. There is growing evidence for the use of Compassionate Mind Training (CMT). CMT aims to reduce feelings of self-criticism and shame which are commonly reported by adults experiencing the menopause, by helping individuals to take better care of themselves, known as self-compassion. Findings show menopausal individuals who are more self-critical may be more vulnerable to difficulties during menopause. Therefore, CMT could help manage this. CMT improves self-compassion and reduces depressive symptoms, with group formats found to be more effective than individual or self-help. A previous study of online self-help CMT for the menopause received positive feedback for the therapy and people improved in several areas including self-compassion. Clearly, there could be benefits to offering CMT as a treatment for menopause. Given that group CMT is effective in other populations and groups are more economical and practical for the NHS, this study is interested in looking at the impact of group CMT on menopause.

This study aims to find out how practical and suitable group CMT is for improving the wellbeing of adults experiencing the menopause, and what their views are on the therapy and taking part in the study. To measure the aims, we will look at the ease of recruiting people to the study, whether they are happy to be randomly allocated to receive the therapy or not, whether they stay in the study, the number of completed questionnaires and feedback from participants. It will also look at whether there have been any changes in different domains e.g. anxiety and self-compassion. This will be done through a variety of quantitative and qualitative outcomes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • County
      • London, County, United Kingdom, WC1E 6BT
        • University College London

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adults (aged 40-60) who are biologically female
  • Women who are experiencing symptoms of the menopause or peri-menopause; which is naturally occurring. This is identified through the STRAW criteria. Individuals have to answer Yes on at least one of the STRAW screening questions to ensure women are in the perimenopause or menopausal period.
  • Substantial English verbal communication and comprehension skills
  • Capacity to consent
  • Confident in using video conferencing applications (MsTeams)
  • Willingness to take part in a post-intervention interview about their experience.
  • PHQ-9 score 5-19 (mild to moderate clinical cut offs)
  • GAD-7 score 5-15 (mild to moderate clinical cut offs)

Exclusion Criteria:

  • People under the age of 40
  • People currently receiving any form of psychology intervention.
  • Transgender females who are biologically male
  • More than 5 years post menopause.
  • PHQ-9 score greater or equal to 20 (severe clinical cut off)
  • GAD-7 score greater or equal to 15 (severe clinical cut off)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Treatment as usual
Experimental: Online CMT groups
Online Compassionate Mind Training
Participants will attend 6 x 90-minute online CMT sessions. CMT is delivered by combining taught information, exercises, and practices. It is effective, so the aim is to explore its use with menopausal women.
Other Names:
  • CMT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Revised Women's Health Questionnaire
Time Frame: To be completed within one week before and within one week after the intervention
Measures health-related quality of life by measuring perceptions of physical and emotional experiences of middle-aged women. All subscales are scored from yes, definitely (1) to no, not at all (4) with subscales scored with a scoring algorithm transforming each score to a 0-100 scale.
To be completed within one week before and within one week after the intervention
36-Item Short Form Survey
Time Frame: To be completed within one week before and within one week after the intervention
Measures quality of life. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.
To be completed within one week before and within one week after the intervention
The Menopause Representations Questionnaire (MRQ)
Time Frame: To be completed within one week before and within one week after the intervention
Measure to assess beliefs about menopause. It consists of 20 items, scored either no (0), uncertain (1) or yes (2). Higher scores indicate more beliefs about the menopause.
To be completed within one week before and within one week after the intervention
Fears of Compassion Scale
Time Frame: To be completed within one week before and within one week after the intervention
Measures fears of compassion. It has 38 items, scored either dont agree at all (0) to completely agree (4) on a Likert scale. There are three subscales, subscale items are summed, with higher scores indicating higher fears of compassion.
To be completed within one week before and within one week after the intervention
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: To be completed within one week before and within one week after the intervention
Measures severity of depression. Score from 0-27, higher scores represent higher severity of symptoms of depression.
To be completed within one week before and within one week after the intervention
General Anxiety Disorder-7 (GAD-7)
Time Frame: To be completed within one week before and within one week after the intervention
Measures severity of anxiety. Score from 0-21, higher scores represent higher severity of symptoms of anxiety.
To be completed within one week before and within one week after the intervention
The forms of Self Criticising/Attaching & Self-reassuring scale (FSCRS) SELF-REASSURING SCALE (FSCR
Time Frame: To be completed within one week before and within one week after the intervention
Measures self criticism and the ability to self-reassure. It is a 22-item scale with the items making up three components; inadequate self, hatred self and self-reassure. Responses are given on a 5-point likert scale (0 = not at all lime me, to 4 = extremely like me). Higher scores indicate a greater sense of inadequacy (score 0-20), self-hate (score 0-16), and self-reassurance (score 0-20).
To be completed within one week before and within one week after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post intervention interviews
Time Frame: Within 5 weeks post intervention
Qualitative data on experiences from the group
Within 5 weeks post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Aimee Spector, UCL

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 20, 2024

Primary Completion (Actual)

October 23, 2025

Study Completion (Actual)

October 23, 2025

Study Registration Dates

First Submitted

June 11, 2024

First Submitted That Met QC Criteria

June 11, 2024

First Posted (Actual)

June 17, 2024

Study Record Updates

Last Update Posted (Actual)

May 7, 2026

Last Update Submitted That Met QC Criteria

May 1, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 26701/001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Menopause

Clinical Trials on Compassionate Mind Training

Subscribe